159 related articles for article (PubMed ID: 8849959)
1. Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy.
Sugarbaker PH
Cancer Treat Res; 1996; 82():317-25. PubMed ID: 8849959
[TBL] [Abstract][Full Text] [Related]
2. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
Sugarbaker PH; Jablonski KA
Ann Surg; 1995 Feb; 221(2):124-32. PubMed ID: 7857141
[TBL] [Abstract][Full Text] [Related]
3. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
Pestieau SR; Sugarbaker PH
Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
5. Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy.
Sugarbaker PH; Chang D; Koslowe P
Cancer Treat Res; 1996; 81():89-104. PubMed ID: 8834578
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal chemotherapy for peritoneal carcinomatosis from colonic or appendiceal cystadenocarcinoma: rationale and results of treatment.
Sugarbaker PH; Landy D; Pascal R
Prog Clin Biol Res; 1990; 354B():141-70. PubMed ID: 2236162
[TBL] [Abstract][Full Text] [Related]
7. Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis.
Van der Speeten K; Stuart OA; Chang D; Mahteme H; Sugarbaker PH
Cancer Chemother Pharmacol; 2011 Jul; 68(1):147-56. PubMed ID: 20857115
[TBL] [Abstract][Full Text] [Related]
8. Peritonectomy and intraperitoneal chemotherapy in appendiceal and colorectal cancer.
Horsell KW; Merten S; Clingan P; King DW; Morris DL
Aust N Z J Surg; 1999 Oct; 69(10):729-32. PubMed ID: 10527351
[TBL] [Abstract][Full Text] [Related]
9. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.
Sugarbaker PH; Chang D
Ann Surg Oncol; 1999 Dec; 6(8):727-31. PubMed ID: 10622499
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
Loggie BW; Fleming RA; McQuellon RP; Russell GB; Geisinger KR
Am Surg; 2000 Jun; 66(6):561-8. PubMed ID: 10888132
[TBL] [Abstract][Full Text] [Related]
12. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix.
Sugarbaker PH; Landy D; Jaffe G; Pascal R
Cancer; 1990 Apr; 65(7):1495-501. PubMed ID: 2107021
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
Lam JY; McConnell YJ; Rivard JD; Temple WJ; Mack LA
Am J Surg; 2015 Sep; 210(3):424-30. PubMed ID: 26051744
[TBL] [Abstract][Full Text] [Related]
14. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
Klaver YL; Chua TC; Verwaal VJ; de Hingh IH; Morris DL
J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal carcinomatosis of unknown primary site, a study of 25 patients over 30 years.
Sugarbaker PH
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1908-1911. PubMed ID: 32418756
[TBL] [Abstract][Full Text] [Related]
16. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.
Jacquet P; Stephens AD; Averbach AM; Chang D; Ettinghausen SE; Dalton RR; Steves MA; Sugarbaker PH
Cancer; 1996 Jun; 77(12):2622-9. PubMed ID: 8640714
[TBL] [Abstract][Full Text] [Related]
17. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
Yan TD; Bijelic L; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
[TBL] [Abstract][Full Text] [Related]
18. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin.
Mahteme H; Sugarbaker PH
Br J Surg; 2004 Sep; 91(9):1168-73. PubMed ID: 15449269
[TBL] [Abstract][Full Text] [Related]
19. Morbidity associated with the use of oxaliplatin versus mitomycin C in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal or appendiceal origin: a multi-institutional comparative study.
Benzaquen E; Wang Y; Wiseman S; Rosenfeld V; Sideris L; Dubé P; Pelletier JS; Vanounou T
Can J Surg; 2021 Mar; 64(2):E111-E118. PubMed ID: 33651573
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
